Yahoo
Morningstar

Morningstar

Apr 29, 2026

Haleon plc: Haleon Earnings: Weak Consumer Health Pressures Volume, but Bright Spots Still Exist

Symbols

HLN

Sector(s)

Healthcare

Rating

Current Price

9.38

Fair Value

Economic Moat

Stewardship

Summary

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs an

Upgrade to begin using premium research reports and get so much more.

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level

Upgrade
Mobilize your Website
View Site in Mobile | Classic
Share by: